D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis

Thromb Res. 2015 Apr;135(4):673-8. doi: 10.1016/j.thromres.2015.02.007. Epub 2015 Feb 14.

Abstract

Background: D-dimer role is well established in the diagnostic work-up for lower limb deep vein thrombosis (DVT), however it has not been formally tested for clinically suspected upper extremity DVT and/or superficial vein thrombosis (SVT).

Aim: To ascertain D-dimer diagnostic accuracy for upper extremity DVT and/or SVT.

Study design: We performed a single centre management study in outpatients referred by emergency or primary care physicians for clinically suspected upper extremity DVT. All patients underwent D-dimer testing (cut-off value: ≤500 ng/mL), and a B-mode and color Doppler ultrasonography examination. In case of either technical problems or anatomical barriers, ultrasonography was repeated after 5-7 days. All patients were followed up for three months for the occurrence of symptomatic DVT and/or SVT and/or pulmonary embolism.

Results: We enrolled 239 patients (F: 63.6%; mean±SD age: 58.3±16.8). At the initial diagnostic work-up, DVT was detected in 24 (10%) patients while SVT in 35 (14.6%) patients. During follow-up, one upper extremity DVT was found. D-dimer levels were higher in patients with DVT than in those without. Sensitivity and specificity of D-dimer for DVT were 92% (95%CI: 73-99%) and 60% (95%CI: 52-67%) respectively, with a negative predictive value of 98% (95%CI: 93-100%), whereas for SVT they were 77% (95%CI: 59-89%) and 60% (95%CI: 52-67%) respectively, with a negative predictive value of 93% (95%CI: 86-97%).

Conclusions: D-dimer has a negative predictive value ≥93% for excluding DVT in symptomatic outpatients and it can be a useful test in the diagnostic work-up of suspected upper extremity DVT.

Keywords: D-dimer; Diagnosis; Superficial vein thrombosis; Ultrasonography; Ultrasound imaging; Upper extremity deep vein thrombosis.

MeSH terms

  • Antifibrinolytic Agents / administration & dosage
  • Antifibrinolytic Agents / therapeutic use*
  • Female
  • Fibrin Fibrinogen Degradation Products / administration & dosage
  • Fibrin Fibrinogen Degradation Products / therapeutic use*
  • Humans
  • Male
  • Prospective Studies
  • Ultrasonography
  • Upper Extremity Deep Vein Thrombosis / diagnostic imaging
  • Upper Extremity Deep Vein Thrombosis / drug therapy*

Substances

  • Antifibrinolytic Agents
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D